Atossa Therapeutics Inc (ATOS)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
Mar 28, 16:00
1.82
+0.03
(+1.68%)
After-Hours: 20:00
Atossa Therapeutics Cash from Operations (TTM): -19.89M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -19.89M |
June 30, 2023 | -21.42M |
March 31, 2023 | -22.90M |
December 31, 2022 | -20.76M |
September 30, 2022 | -19.90M |
June 30, 2022 | -17.55M |
March 31, 2022 | -16.94M |
December 31, 2021 | -16.47M |
September 30, 2021 | -16.24M |
June 30, 2021 | -15.86M |
March 31, 2021 | -12.75M |
December 31, 2020 | -11.57M |
September 30, 2020 | -10.85M |
June 30, 2020 | -9.937M |
March 31, 2020 | -10.21M |
December 31, 2019 | -9.128M |
September 30, 2019 | -8.864M |
June 30, 2019 | -9.393M |
March 31, 2019 | -8.724M |
December 31, 2018 | -8.962M |
September 30, 2018 | -8.201M |
June 30, 2018 | -7.604M |
March 31, 2018 | -7.120M |
December 31, 2017 | -6.594M |
Date | Value |
---|---|
September 30, 2017 | -6.267M |
June 30, 2017 | -3.930M |
March 31, 2017 | -4.241M |
December 31, 2016 | -5.375M |
September 30, 2016 | -7.972M |
June 30, 2016 | -12.09M |
March 31, 2016 | -13.95M |
December 31, 2015 | -13.95M |
September 30, 2015 | -12.72M |
June 30, 2015 | -12.22M |
March 31, 2015 | -10.95M |
December 31, 2014 | -10.56M |
September 30, 2014 | -10.48M |
June 30, 2014 | -10.24M |
March 31, 2014 | -10.10M |
December 31, 2013 | -8.83M |
September 30, 2013 | -8.114M |
June 30, 2013 | -5.527M |
March 31, 2013 | -4.230M |
December 31, 2012 | -3.90M |
September 30, 2012 | -3.006M |
June 30, 2012 | -4.200M |
March 31, 2012 | -4.491M |
December 31, 2011 | -3.492M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-22.90M
Minimum
Mar 2023
-8.724M
Maximum
Mar 2019
-14.70M
Average
-15.86M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -29.67M |
Electromed Inc | 4.872M |
Xtant Medical Holdings Inc | -10.89M |
Asensus Surgical Inc | -63.63M |
Senseonics Holdings Inc | -70.16M |